Therapeutic Areas

Until the acquisition of CeNeS Pharmaceuticals PAION's therapeutic emphasis was on the field of stroke and other thrombotic diseases, diseases which are caused by the obstruction of a blood vessel by a blood clot. Through the acquisition of CeNeS, PAION expanded its target indications to the field of central nervous system (CNS) disorders.